Abbott Laboratories vs. Summit Therapeutics Inc. Common Stock
Abbott Laboratories and Summit Therapeutics Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | SMMT | |
|---|---|---|
| Market Cap | $178.40 billion | $12.58 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | SMMT | |
|---|---|---|
| Dividend Yield | 2.46% | — |
ABT and SMMT split the dividend factors evenly.
Risk & Sentiment
| ABT | SMMT | |
|---|---|---|
| Short Interest | 0.57% | 0.00% |
SMMT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, SMMT overview, SMMT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.